AugEstablished in August, 1990 registered in Taipei city; initial capital NTD 1billion.

AugSet up first Meltblown production line.

JanISO9001:2000 certificate approval.

MaySet up second Meltblown production line.

FebSet up third Meltblown production line.

MaySet up fourth Meltblown production line.

JanSet up fifth Meltblown production line.
ShareHope Medicine Inc. became Mytrex shareholding company acquired 4,520 thousand shares, shareholding ratio is 69.54%.

FebISO9001:2008 certificate approval.

JulInitial Public Offering.

AugIPO in ROTC

AprNT $20 million cash capital increase; Total paid-in capital of NT $ 140 million. Founded Min-Hong Non-woven Technology Co., Ltd., Shanghai.

OctPaid-in capital totaled 148 million after capitalization of retained earnings of NT $8.4 million. Invest in Jie-Bang and acquired 80% of shareholding.

NovEstablished Medical Biotechnology Division; core business are cloth leasing and special medical supply.

JunZhongli plant inaugurated.

SepCapitalization of retained earnings of NT$ 7.42 million; totaled paid-in capital result NT $155 million.

OctProduction lines moved to No.545, Sec. 2, Hezun N. Rd., Zhongli City, Taoyuan County 320, Taiwan.

DecSold Xingwu plant.

JanSold Min-Hong Non-woven Technology Co., Ltd., Shanghai

MarRenamed business unit: High-Tech Material Division and Medical Biotechnology Division

AprThe exercise of employee stock purchase plan which increase total paid-in capital to 156 million.

JulThe exercise of employee stock purchase plan which increase total paid-in capital to 156 million.

AugCapitalization of retained earnings of 7.79 million; totaled paid-in capital of 164 million.

MayInvest in the establishment in Power Membrane Co., Ltd., total investment of NT $15 million, shareholding ratio is 75%.

JulThe exercise of employee stock purchase plan which increase total paid-in capital to 165 million.

AugPaid-in capital totaled NT $173 million after capitalization of retained earnings of NT $8 million.

DecCapital increase in Jie-Bang, the amount of investment NT $10 million, shareholding ratio is 81.8%

Apremployees exercise stock options, paid-in capital increased to $173 million.

FebISO9001:2015 certificate approval.

AugCapitalization of retained earnings of 9.59 million; totaled paid-in capital of 201 million.

NovISO13485:2016 certificate approval.

SepDisposal of the entire equity of Giant Bonding Scientific Co.

Aug390 units of employee stock options were issued, each unit can subscribe for 1,000 shares.

AugIncreased capital by cash in TSVC Co., California, USA, with an investment of US$800,000 for shareholding ratio of 88.89%.

Septhe surplus NT$4,129,000 was transferred to capital and the paid-in capital was NT$210,570,000 after the capital increase.

Oct110 units of employee stock options were issued, each unit can subscribe for 1,000 shares.

Deccash capital increased to NT$33,000,000. After the capital increase, the paid-in capital amounted to NT$243,570,000.

Septhe surplus NT$121,785,000 was transferred to capital, and the paid-in capital after the capital increase was NT$365,355,000.

OctMeltblown nonwoven and medical cloth business was divided and transferred to the newly established subsidiary Mytrex Industries Inc., which is 100% owned by the company.